GOINPHARMA: 24/7 Breaking News about pharma, healtcare, chemistry
Wednesday, 12 December 2018 - 8:39

Top stories

News of the week

Bacterial flora: a possible solution to cure autism

The importance of intestine flora in regulating organism’s balance and in the onset of certain diseases is drawing increasing interest among researchers. An interesting study on the issue has been conducted by a team of researchers from Baylor College of…

Approvals

Procedures / New drug and device authorizations / Recommendations

Loxo Oncology’s cancer drug approved

Stamford, Connecticut-based Loxo Oncology has informed that FDA has approved Vitrakvi (larotrectinib), the first TRK inhibitor for the treatment of solid cancer types with genetic mutations in receptors. Vitrakvi is the first cancer treatment with a nearly agnostic approach to…

Companies

Healthcare market news

Fresenius lowers guidance and shares decline 15%

Germany-based group Fresenius’ CEO Stephan Sturm has announced during a conference call to investors that the management has lowered the guidance for the near future and now expects the company won’t be able to reach the sales and profit target…

Chemistry

Market and Technology

Behind the scenes of Bayer-Monsanto deal

The Wall Street Journal today has published a long article rehearsing the history of Monsanto acquisition by Germany-based Bayer. The deal is the result of new CEO Werner Baumann’s perseverance: for years, he had been seeking to convince the top…

M&A

Mergers & Acquisitions

Japan’s Taisho submits its offer to buy BMS’ Upsa (€1bn)

Italian daily Il Messaggero some days ago reported 4 bids for France-based Upsa, put up for sale by US-based group Bristol-Myers Squibb. The article added that pharmaceutical group Angelini made a more profitable bid than private equities PAI Partners and…

Nutraceuticals

Food supplements

Vitamin D myth starts shaking

The New York Times has published today a long article about the controversial views on vitamin D in the scientific community and its economic implications. One of the most fervent supporters of vitamin D, convinced that it brings high benefit…

Pathology

Latest developments

Bacterial flora: a possible solution to cure autism

The importance of intestine flora in regulating organism’s balance and in the onset of certain diseases is drawing increasing interest among researchers. An interesting study on the issue has been conducted by a team of researchers from Baylor College of…

Safety

News on Product Safety

FDA issues warning about Intercept’s Ocaliva after 19 patients died

The FDA has officially warned doctors about the risks from Intercept Pharmaceuticals’ Ocaliva (obeticholic acid), after 19 patients on Intercept’s drug, developed to treat PBC (Primary Biliary Cholangitis) had died. The FDA, anyway, has specified that the deaths have occurred…

Trials

Preclinical Trials / Clinical Trials / Epidemiology

Germany-based MorphoSys announces excellent clinical results from investigational lymphoma therapy

Shares of the Munich-based biotech MorphoSys today have increased by 2.8% (Frankfurt) reflecting the positive clinical results reported at the American Society of Hematology Congress, held in San Diego in these days. Specifically, the results come from clinical trial L-Mind,…